InvestSMART

Cogstate Limited (ASX: CGS) - Announcements

Current share price for CGS : $3.370 0.02 (0.59%)+

ASX company news and announcements for Cogstate Limited (CGS) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Cogstate Limited (CGS) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Cogstate Limited (CGS), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Cogstate Limited (CGS)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$582 Appendix 3B (placement) 12 May 2015 11:36AM $0.215 $3.370 risen by 1,467.44%
$582 Non-Executive Director Appointment and Private Placement 12 May 2015 11:36AM $0.215 $3.370 risen by 1,467.44%
$582 Trading Halt 12 May 2015 10:09AM $0.215 $3.370 risen by 1,467.44%
$582 Appendix 4C - quarterly 28 Apr 2015 10:06AM $0.230 $3.370 risen by 1,365.22%
$582 Business Update 28 Apr 2015 10:04AM $0.230 $3.370 risen by 1,365.22%
$582 Cogstate signs US$4.9m sales contract 27 Apr 2015 8:37AM $0.175 $3.370 risen by 1,825.71%
$582 Proposed Issue of Unlisted Options 19 Mar 2015 10:52AM $0.160 $3.370 risen by 2,006.25%
$582 Appendix 4D and Half-Year Financial Report 18 Feb 2015 9:09AM $0.185 $3.370 risen by 1,721.62%
$582 Business update 8 Jan 2015 10:49AM $0.200 $3.370 risen by 1,585%
$582 Chairman's Address to Shareholders 23 Oct 2014 9:36AM $0.240 $3.370 risen by 1,304.17%
$582 Appendix 4C - quarterly 22 Oct 2014 4:13PM $0.235 $3.370 risen by 1,334.04%
$582 Cogstate enters into Letter of Intent for sale of Axon Sport 22 Oct 2014 3:03PM $0.240 $3.370 risen by 1,304.17%
$582 Precision Recruitment chosen for phase III Alzheimers study 10 Sep 2014 5:04PM $0.270 $3.370 risen by 1,148.15%
$582 Cogstate Test Provides Better Assessment than Observation 25 Aug 2014 12:51PM $0.280 $3.370 risen by 1,103.57%
$582 Appendix 4E and Preliminary Final Report 20 Aug 2014 9:45AM $0.280 $3.370 risen by 1,103.57%
$582 Contracts signed since 1 July 2014 hit $9 million 14 Aug 2014 9:20AM $0.290 $3.370 risen by 1,062.07%
$582 Cogstate signs $7.3 million sales contract 5 Aug 2014 9:28AM $0.280 $3.370 risen by 1,103.57%
$582 Appendix 4C - quarterly 22 Jul 2014 1:06PM $0.250 $3.370 risen by 1,248%
$582 Cogstate provides update on sales contracts 24 Jun 2014 9:22AM $0.300 $3.370 risen by 1,023.33%
$582 Cogstate signs first client to Precision Recruitment 12 Jun 2014 8:57AM $0.255 $3.370 risen by 1,221.57%
$582 Business update and guidance on FY14 results 6 Jun 2014 8:29AM $0.245 $3.370 risen by 1,275.51%
$582 Cogstate announces updated agreement with Merck Canada 2 Jun 2014 9:32AM $0.240 $3.370 risen by 1,304.17%
$582 Appendix 4C - quarterly 28 Apr 2014 12:00PM $0.315 $3.370 risen by 969.84%
$582 Cogstate technology chosen for major Phase III trial 24 Mar 2014 2:08PM $0.320 $3.370 risen by 953.13%
$582 Business Update - Significant growth in future revenue 18 Feb 2014 3:19PM $0.385 $3.370 risen by 775.32%

851 - 875 of 1013 results

Page 35 of 41

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.